A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2009
11/05/2009	CA2722628A1 Super fast-acting insulin compositions
11/04/2009	CN101573133A PEGylated, extended insulins
11/04/2009	CN101569687A Herbal medicine for osteoporosis and related conditions
11/03/2009	US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009	US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009	US7611727 Pharmaceutical composition for transdermal or transmucous administration
11/03/2009	CA2383220C Controlled release pellet formulation
11/03/2009	CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
11/03/2009	CA2353133C Treatment of disorders secondary to organic impairments
10/2009
10/29/2009	WO2009131191A1 Metastin derivative and use thereof
10/29/2009	WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	WO2009129696A1 A kind of receptor signaling transoluction positive modulators, preparation methods and uses thereof
10/29/2009	WO2009111574A3 BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
10/29/2009	WO2009059806A3 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
10/29/2009	US20090270507 Concentrated Liquid Thyroid Hormone Composition
10/29/2009	DE102007049630A1 New amide compounds used for therapy and/or prophylaxis of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy
10/29/2009	CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/28/2009	EP2112161A2 Peptides that lower blood glucose levels
10/28/2009	EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin
10/28/2009	EP1497438B1 Means and methods for the production of adenovirus vectors
10/28/2009	EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009	CN101568547A Substituted estratrien derivatives as 17beta hsd inhibitors
10/28/2009	CN101565429A Inhibitors of dipeptidylpeptidase iv
10/28/2009	CN101564512A Quality control method of hyperthyroidism resistance powder
10/28/2009	CN100553675C Process of preparing calcitonin microsphere
10/28/2009	CN100553637C Hormone composition
10/28/2009	CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/27/2009	US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009	US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009	US7608628 Alkylsulphonamide quinolines
10/27/2009	US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
10/27/2009	US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
10/27/2009	US7608253 end-capped polyethylene glycol carbamate derivatives useful as water-soluble pro-drugs; controll hydrolytic degradation of hydrogels; conjugate polymer drug for controlled release
10/27/2009	CA2162366C Conjugation-stabilized polypeptide compositions
10/22/2009	WO2009128936A2 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants
10/22/2009	WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009	WO2009128360A1 Therapeutic agent for diabetes
10/22/2009	WO2009127686A1 Novel estrogen receptor ligands
10/22/2009	US20090264534 Selective androgen receptor modulators
10/22/2009	US20090264396 17Alpha, 21-Dihydroxypregnene esters as antiandrogenic agents
10/22/2009	US20090264367 5-cnac as oral delivery agent for parathyroid hormone fragments
10/22/2009	US20090264365 Conformationally constrained parathyroid hormone (pth) analogs
10/22/2009	CA2721506A1 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants
10/22/2009	CA2720215A1 Novel estrogen receptor ligands
10/21/2009	EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009	EP2109618A1 Nitric oxide releasing steroids
10/21/2009	EP2109617A1 Nitric oxide releasing steroids
10/21/2009	EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009	EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances
10/21/2009	CN101559086A Medicine and healthcare products made from leaves of hippophaes rhamnoides L. for replenishing estrogen
10/21/2009	CN101559062A Quinazoline derivatives which promote the release of parathyroid hormone
10/21/2009	CN101558870A Mulberry and sea backthern concentrated food
10/21/2009	CN100551439C Long acting injectable insulin composition and methods of making and using thereof
10/20/2009	US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009	US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy
10/20/2009	CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009	CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009	CA2378428C Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
10/20/2009	CA2330183C Novel insulin analogs with enhanced zinc binding
10/20/2009	CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
10/15/2009	WO2009126923A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof
10/15/2009	WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009	WO2009019138A3 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
10/15/2009	US20090258949 Amorphous form of cinacalcet
10/15/2009	US20090258884 Substituted amides
10/15/2009	CA2721080A1 Estrogenic extracts of anemarrhena asphodeloides bge. from the liliaceae family and uses thereof
10/14/2009	EP2108363A1 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same
10/14/2009	EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009	CN101557827A Pharmaceutical compositions comprising HGH for oral delivery
10/14/2009	CN100548976C Sulfonamide derivatives for the treatment of diseases
10/14/2009	CN100548283C Prevention and treatment of androgen-deprivation induced osteoporosis
10/13/2009	US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009	US7601799 Methods and means to promote gut absorption
10/13/2009	US7601687 Drug screening for non-insulin dependent diabetes mellitus, beta cell dysfunction and peripheral insulin resistance
10/13/2009	CA2392620C Use of melatonin for the treatment of androgenetic and diffuse alopecia
10/13/2009	CA2356331C Methods for glucagon suppression
10/13/2009	CA2319515C Anhydrous topical skin preparations
10/08/2009	WO2009121910A1 Indene derivatives as estrogen receptor ligands
10/08/2009	WO2009121210A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009	US20090253736 Azaindole derivatives as cftr modulators
10/08/2009	US20090253643 Equol level regulator
10/08/2009	US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
10/08/2009	CA2720306A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009	CA2714996A1 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
10/07/2009	EP2107069A2 Novel insulin derivatives
10/07/2009	EP2106260A1 Insulin sensitisers and methods of treatment
10/07/2009	EP1537113B1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/07/2009	EP1392389B1 Microprojection array having a beneficial agent containing coating
10/07/2009	EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009	EP1311249B1 Set of transdermal therapeutic systems
10/07/2009	CN101549072A Traditional Chinese medicine composition for curing hyperthyrea
10/07/2009	CN101549046A Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma
10/06/2009	US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009	US7598272 Kinase inhibitors
10/06/2009	US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
10/06/2009	CA2391430C Improved transdermal contraceptive delivery system and process
10/06/2009	CA2245151C Improved process for obtaining insulin precursors having correctly bonded cystine bridges
10/01/2009	WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009	US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009	US20090246232 Pharmaceutical composition

1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 290